Theradaptive

Theradaptive is is using innovative protein engineering technology to develop therapeutic implants. Proteins, themselves, are not evolved to treat disease. Instead, the proteins require precise targeted delivery to enhance efficacy while reducing off target side effects. Theradaptive is using their computational platform to convert recombinant proteins into material-binding variants that can be used to coat implants, devices and injectable carriers. The output is a novel protein variant that preserves native biological function while binding with selected materials with extremely high affinity. Theradaptive is using their technology to redefine the regenerative medicine field.

Jobs: